leo: extract claims from 2026-04-22-rand-ai-action-plan-biosecurity-primer

- Source: inbox/queue/2026-04-22-rand-ai-action-plan-biosecurity-primer.md
- Domain: grand-strategy
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Leo <PIPELINE>

domains/grand-strategy/anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities.md

@@ -30,3 +30,10 @@ The AI Action Plan's authorship and enforcement architecture confirms the decoup
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR documents that the AI Action Plan calls for mandatory nucleic acid synthesis screening for federally funded institutions while not replacing DURC/PEPP institutional review. This represents a category substitution: input screening (nucleic acid synthesis) replaces research decision oversight (institutional review), addressing a different layer of the biosecurity problem. The plan reinforces CAISI's role in evaluating frontier AI systems for bio risks, shifting governance authority from science agencies to national security apparatus.
+
+
+## Extending Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND's framing of the AI Action Plan's biosecurity components as addressing 'AI-bio convergence risk' at the synthesis/screening layer confirms the structural decoupling: AI governance instruments (CAISI evaluation, synthesis screening) operate at different pipeline stages than traditional biosecurity institutional review (DURC/PEPP committees deciding whether research programs should exist). The governance gap exists because these are different stages of the research pipeline, not equivalent governance instruments.

domains/grand-strategy/biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship.md

@@ -10,7 +10,7 @@ agent: leo
 sourced_from: grand-strategy/2026-04-22-cset-georgetown-ai-action-plan-recap.md
 scope: structural
 sourcer: CSET Georgetown
-related: ["strategic-interest-alignment-determines-whether-national-security-framing-enables-or-undermines-mandatory-governance", "anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities"]
+related: ["strategic-interest-alignment-determines-whether-national-security-framing-enables-or-undermines-mandatory-governance", "anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities", "biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship"]
 ---
 
 # Biosecurity governance authority shifted from science agencies to national security apparatus through AI Action Plan authorship
@@ -23,3 +23,10 @@ The White House AI Action Plan (July 23, 2025) lists three co-authors: OSTP Dire
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR notes the AI Action Plan reinforces CAISI's (Center for AI Security and Innovation) role in evaluating frontier AI systems for national security risks including bio risks. This confirms the authority shift pattern where AI-bio convergence governance moves from science agencies (which administered DURC/PEPP) to national security apparatus (CAISI).
+
+
+## Supporting Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND's analysis confirms the AI Action Plan addresses biosecurity through three national security-oriented instruments (nucleic acid synthesis screening requirements, OSTP-convened data sharing mechanism, CAISI evaluation) rather than through science agency institutional review mechanisms, supporting the authority shift thesis.

domains/grand-strategy/durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline.md

@@ -37,3 +37,10 @@ Council on Strategic Risks' July 2025 review of the AI Action Plan confirms the
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 Council on Strategic Risks review of the AI Action Plan (July 2025) confirms the plan explicitly acknowledges AI can provide 'step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal' but does not replace the DURC/PEPP institutional review framework. This is the authoritative biosecurity source documenting that the governance vacuum persists even after the AI Action Plan's release, and that the plan's authors made a deliberate choice to acknowledge the risk without restoring institutional oversight mechanisms.
+
+
+## Extending Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND analysis confirms the specific governance gap: AI Action Plan addresses AI-bio convergence risk at the synthesis/screening layer (nucleic acid synthesis screening requirements, OSTP data sharing mechanism, CAISI evaluation) but leaves the institutional oversight layer ungoverned. None of these instruments replace DURC/PEPP institutional review committee structure. RAND describes this as 'institutions left without clear direction on which experiments require oversight reviews,' confirming the category substitution between output screening and input oversight.